Accord Anastrozole 1 mg FC Tablets
PDF Leaflet Revision Date: 11 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of early and advanced breast cancer in postmenopausal women.
Dosage (summary)
1 mg tablet once daily for adults and elderly.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Tamoxifen
- Estrogen-containing therapies
Contraindications
- Hypersensitivity to anastrozole
- Pre-menopausal women
- Severe renal impairment
- Pregnant and lactating women
- Moderate or severe hepatic disease
Common side effects
- Headache
- Hot flushes
- Nausea
- Rash
- Arthralgia
Counselling Points
- Monitor bone health regularly.
- Avoid pregnancy during treatment.
- Report any unusual symptoms.
Serious warnings
- May reduce bone mineral density, increasing fracture risk.
Important Disclaimer
The Accord Anastrozole 1 mg FC Tablets professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
